These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 11236957

  • 1. Surrogate biomarkers of HPV infection in cervical neoplasia screening and diagnosis.
    Keating JT, Ince T, Crum CP.
    Adv Anat Pathol; 2001 Mar; 8(2):83-92. PubMed ID: 11236957
    [Abstract] [Full Text] [Related]

  • 2. Carbonic anhydrase IX and human papillomavirus as diagnostic biomarkers of cervical dysplasia/neoplasia in women with a cytologic diagnosis of atypical glandular cells: a Gynecologic Oncology Group study in United States.
    Liao SY, Rodgers WH, Kauderer J, Bonfiglio TA, Walker JL, Darcy KM, Carter R, Hatae M, Levine L, Spirtos NM, Stanbridge EJ.
    Int J Cancer; 2009 Nov 15; 125(10):2434-40. PubMed ID: 19670419
    [Abstract] [Full Text] [Related]

  • 3. MN and Ki67 (MIB-1) in uterine cervix carcinoma: novel biomarkers with divergent utility.
    Costa MJ.
    Hum Pathol; 1996 Mar 15; 27(3):217-9. PubMed ID: 8600033
    [No Abstract] [Full Text] [Related]

  • 4. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.
    Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, Bogers J, Dachez R, Denton K, Hariri J, Keller T, von Knebel Doeberitz M, Neumann HH, Puig-Tintore LM, Sideri M, Rehm S, Ridder R, PALMS Study Group.
    J Natl Cancer Inst; 2013 Oct 16; 105(20):1550-7. PubMed ID: 24096620
    [Abstract] [Full Text] [Related]

  • 5. Viral and histopathologic correlates of MN and MIB-1 expression in cervical intraepithelial neoplasia.
    Resnick M, Lester S, Tate JE, Sheets EE, Sparks C, Crum CP.
    Hum Pathol; 1996 Mar 16; 27(3):234-9. PubMed ID: 8600036
    [Abstract] [Full Text] [Related]

  • 6. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
    Ovestad IT, Dalen I, Hansen E, Loge JL, Dybdahl BM, Dirdal MB, Moltu P, Berland JM.
    Cancer Cytopathol; 2017 Apr 16; 125(4):283-291. PubMed ID: 27918650
    [Abstract] [Full Text] [Related]

  • 7. Ki-67, cyclin E, and p16INK4 are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia.
    Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, Duensing S, Sheets EE, Munger K, Crum CP.
    Am J Surg Pathol; 2001 Jul 16; 25(7):884-91. PubMed ID: 11420459
    [Abstract] [Full Text] [Related]

  • 8. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Wright TC, Behrens CM, Ranger-Moore J, Rehm S, Sharma A, Stoler MH, Ridder R.
    Gynecol Oncol; 2017 Jan 16; 144(1):51-56. PubMed ID: 28094038
    [Abstract] [Full Text] [Related]

  • 9. p16INK4A, CDC6, and MCM5: predictive biomarkers in cervical preinvasive neoplasia and cervical cancer.
    Murphy N, Ring M, Heffron CC, King B, Killalea AG, Hughes C, Martin CM, McGuinness E, Sheils O, O'Leary JJ.
    J Clin Pathol; 2005 May 16; 58(5):525-34. PubMed ID: 15858126
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Utility of p16, Ki-67, and HPV test in diagnosis of cervical intraepithelial neoplasia and atrophy in women older than 50 years with 3- to 7-year follow-up.
    Jackson JA, Kapur U, Erşahin Ç.
    Int J Surg Pathol; 2012 Apr 16; 20(2):146-53. PubMed ID: 22104735
    [Abstract] [Full Text] [Related]

  • 12. Dual p16 and Ki-67 Expression in Liquid-Based Cervical Cytological Samples Compared to Pap Cytology Findings, Biopsies, and HPV Testing in Cervical Cancer Screening: A Diagnostic Accuracy Study.
    Prigenzi KCK, Heinke T, Salim RC, Focchi GRA.
    Acta Cytol; 2018 Apr 16; 62(2):104-114. PubMed ID: 29566392
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
    Yu LL, Chen W, Lei XQ, Qin Y, Wu ZN, Pan QJ, Zhang X, Chang BF, Zhang SK, Guo HQ, Qiao YL.
    Oncotarget; 2016 Apr 19; 7(16):21181-9. PubMed ID: 27029033
    [Abstract] [Full Text] [Related]

  • 16. The association of vascular proliferation with HPV status and epithelial PCNA positivity in cervical intraepithelial lesions.
    Soini Y, Pöllänen R, Kemppainen S, Pääkkö P, Lehto VP.
    APMIS; 1996 Mar 19; 104(3):183-90. PubMed ID: 8611192
    [Abstract] [Full Text] [Related]

  • 17. The significance of HPV L1 and Ki-67 detection in cervical intraepithelial neoplasm screening.
    Luo Y, Cai M, Shen P, Chen H, Yao J.
    Minerva Med; 2019 Dec 19; 110(6):586-587. PubMed ID: 31295980
    [No Abstract] [Full Text] [Related]

  • 18. Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data.
    Uijterwaal MH, Polman NJ, Witte BI, van Kemenade FJ, Rijkaart D, Berkhof J, Balfoort-van der Meij GA, Ridder R, Snijders PJ, Meijer CJ.
    Int J Cancer; 2015 May 15; 136(10):2361-8. PubMed ID: 25345358
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.